4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN
Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Terminates At-the-Market (ATM) Equity Facility
CEO Compensation Update - Brent Lucas Receives Salary Increase and Stock Options
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stockholders Approve Amendments to Equity Incentive and Purchase Plans
Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-Of-Its-Kind Fully Implanted Cochlear Implant
Board Appointment - Charles S. McKhann Joins Envoy Medical, Inc.
Annual Report to Security Holders
Q2
Q1
Amended Annual Report
FY 2025
Q3
FY 2024
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
S-1MEF